TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

por Skomedal, H., Kristensen, G., Helland, A., Nesland, J. M., Kooi, S., Børresen, A. L., Holm, R.
Publicado 1995

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

por Helland, A., Karlsen, F., Due, E. U., Holm, R., Kristensen, G., Børresen-Dale, A. l.
Publicado 1998

Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium

por Pradhan, M., Abeler, V. M., Danielsen, H. E., Sandstad, B., Tropé, C. G., Kristensen, G. B., Risberg, B. Å.
Publicado 2012

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival

por Wang, Y, Helland, Å, Holm, R, Skomedal, H, Abeler, V M, Danielsen, H E, Tropé, C G, Børresen-Dale, A-L, Kristensen, G B
Publicado 2004

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

por Kaye, S, Aamdal, S, Jones, R, Freyer, G, Pujade-Lauraine, E, de Vries, E G E, Barriuso, J, Sandhu, S, Tan, D S-W, Hartog, V, Kuenen, B, Ruijter, R, Kristensen, G B, Nyakas, M, Barrett, S, Burke, W, Pietersma, D, Stuart, M, Emeribe, U, Boven, E
Publicado 2012